Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Equity (2019 - 2025)

AVITA Medical (RCEL) has disclosed Return on Equity for 6 consecutive years, with 4.17% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 418.0% year-over-year to 4.17%, compared with a TTM value of 4.17% through Dec 2025, up 418.0%, and an annual FY2025 reading of 8.0%, up 800.0% over the prior year.
  • Return on Equity was 4.17% for Q4 2025 at AVITA Medical, up from 1.35% in the prior quarter.
  • Across five years, Return on Equity topped out at 4.17% in Q4 2025 and bottomed at 131.44% in Q1 2025.
  • Average Return on Equity over 4 years is 8.22%, with a median of 0.09% recorded in 2024.
  • Peak annual rise in Return on Equity hit 418bps in 2025, while the deepest fall reached -13144bps in 2025.
  • Year by year, Return on Equity stood at 0.09% in 2022, then surged by 84bps to 0.17% in 2023, then tumbled by -105bps to 0.01% in 2024, then surged by 52122bps to 4.17% in 2025.
  • Business Quant data shows Return on Equity for RCEL at 4.17% in Q4 2025, 1.35% in Q3 2025, and 1.17% in Q2 2025.